Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lomotil to Decrease Bowel Activity During FDG PET in Lymphoma
NCT00583323Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2003
- Primary completion
- Sep 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of diphenoxylate hydrochloride + atropine sulfate, sponsored by Mayo Clinic. Started Feb 2003; status: completed.
02
Drugs
diphenoxylate hydrochloride + atropine sulfate
Beyond the preview
Go deeper on NCT00583323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00583323.